Inventaire - your friends and communities are your best library - Inventaire

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC

published in: Antimicrobial Agents and Chemotherapy

date of publication: 2004-02-01

language: English

main subject: pharmacokinetics

Cites articles 117

Date

Title

Authors

2000-05-01

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection
2000-01-01

Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance
2000-03-01

Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.

Jerome J. Schentag
2000-03-01

A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin.
2000-03-01

Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers

Boban M Erovic
2000-01-01

Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
1999-12-01

Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
1999-01-01

Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy
1999-11-01

Pharmacokinetic and pharmacodynamic surrogate markers: studies with fluoroquinolones in patients
1999-10-01

Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation
1999-09-01

In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model
1999-09-01

Pharmacokinetics and pharmacodynamics of antibiotics in meningitis

David Andes
1999-07-01

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials

Min Zhu
1999-03-01

Ten years of ciprofloxacin: the past, present and future. Antimicrobial susceptibility. Introduction
1999-02-01

Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives
1999-03-01

Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model
1999-02-01

An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection
1999-04-01

Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model
1998-11-01

A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities
1998-10-01

In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis
1998-09-01

Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods
1998-08-01

Infection in the intensive care unit: beta-lactamase-mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing.
1998-07-01

Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model
1998-03-01

Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept
1998-03-01

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy,Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Sujata M Bhavnani
1998-01-01

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
1998-07-01

Pharmacodynamic interactions of antibiotics alone and in combination.
1998-06-01

Choosing an antibiotic on the basis of pharmacodynamics
1998-12-01

Pharmacokinetic and pharmacodynamic modelling of antibiotic therapy
1998-07-01

Pharmacodynamics of fluoroquinolones in experimental models of endocarditis
1998-07-01

The pharmacodynamics of beta-lactams
1997-10-01

Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling

Article - wd:Q35637864

Welcome to Inventaire

the library of your friends and communities

you are offline